NORDIMET® PEN
Indications
Nordimet is indicated for the treatment of:
- active rheumatoid arthritis in adult patients,
- polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to nonsteroidal
anti-inflammatory drugs (NSAIDs) has been inadequate,
- moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic
arthritis in adult patients.
- Induction of remission in moderate
steroid-dependent Crohn's disease in
adult patients, in combination with
corticosteroids and for maintenance of
remission, as monotherapy, in patients
who have responded to methotrexate.